KVS Ram Rao appointed Granules India Joint MD, CEO

Rao has previously worked at various companies like Dr Reddys Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.

Published On 2022-01-05 04:00 GMT   |   Update On 2022-01-05 04:00 GMT

New Delhi: Drug firm Granules India on Tuesday announced the appointment of KVS Ram Rao as Joint Managing Director and Chief Executive Officer (CEO) of the company with effect from January 5, 2022. Rao has over two decades of experience in pharmaceutical and chemical industries."During the past few years, we have stressed the importance of building a company around the pillars of efficiency...

Login or Register to read the full article

New Delhi: Drug firm Granules India on Tuesday announced the appointment of KVS Ram Rao as Joint Managing Director and Chief Executive Officer (CEO) of the company with effect from January 5, 2022.

Rao has over two decades of experience in pharmaceutical and chemical industries.

"During the past few years, we have stressed the importance of building a company around the pillars of efficiency and sustainability. Rao's varied experience in the areas of chemical and API businesses including R&D and manufacturing through adoption of innovative technology and best practices in sustainability, will further strengthen Granules' drive towards becoming a strong integrated manufacturer with unparalleled efficiencies,'' Granules India CMD Krishna Prasad Chigurupati said in a statement.

Also Read: Granules India secures USFDA nod for Prazosin Hydrochloride Capsules

Rao has previously worked at various companies like Dr Reddy's Laboratories, Jubilant Life Sciences and Gujarat Heavy Chemicals.

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News